Elevance Health (ELV) director Amy W. Schulman sells 26 common shares

Rhea-AI Filing Summary

Elevance Health, Inc. director Amy W. Schulman reported an open-market sale of common stock. On March 12, 2026, she sold 26 shares of Elevance Health common stock at a price of $287.50 per share. After this transaction, she directly owns 218 shares of Elevance Health common stock.

Insider Trade Summary

Net Seller: 26 shares ($7,475)

Net Sell 1 txn

Insider SCHULMAN AMY W

Role Director

Sold 26 shs ($7K)

Type	Security	Shares	Price	Value
Sale	Common Stock	26	$287.50	$7K

Holdings After Transaction: Common Stock — 218 shares (Direct)

Footnotes (1)

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SCHULMAN AMY W

(Last) (First) (Middle)

220 VIRGINIA AVENUE

(Street)

INDIANAPOLIS INDIANA 46204

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elevance Health, Inc. [ ELV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/12/2026		S		26	D	$287.5	218	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

This Form 4 is being filed late due to a combination of factors. The reported securities were acquired on behalf of the reporting person pursuant to broker discretionary authority prior to the reporting person joining the issuer's board. Due to administrative error, the shares were not reflected in previously reported beneficial ownership totals, including the balance reported following the equity award on February 2, 2026. The shares were sold on behalf of the reporting person pursuant to such discretionary authority, without consultation with or the consent of the reporting person, and the reporting person did not direct the specific transaction. This Form 4 is being filed promptly following discovery of the sale.

	/s/ Kathleen S. Kiefer, Attorney in fact	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Elevance Health (ELV) report for Amy W. Schulman?

Elevance Health reported that director Amy W. Schulman sold 26 shares of common stock in an open-market transaction. The sale occurred at a price of $287.50 per share, and it was reported on a Form 4 insider trading filing.

How many Elevance Health (ELV) shares did Amy W. Schulman sell and at what price?

Amy W. Schulman sold 26 shares of Elevance Health common stock. The transaction was executed at a price of $287.50 per share, according to the Form 4, and was classified as an open-market sale of non-derivative securities.

When did Amy W. Schulman’s Elevance Health (ELV) stock sale take place?

The reported sale by Amy W. Schulman took place on March 12, 2026. On that date, she executed an open-market sale of 26 shares of Elevance Health common stock at a reported price of $287.50 per share.

How many Elevance Health (ELV) shares does Amy W. Schulman hold after the reported sale?

After the reported transaction, Amy W. Schulman directly owns 218 shares of Elevance Health common stock. This post-transaction holding figure comes from the Form 4, which lists total shares beneficially owned following the sale.

Was Amy W. Schulman’s Elevance Health (ELV) transaction a buy or a sell?

The transaction reported for Amy W. Schulman was a sale of Elevance Health shares. The Form 4 classifies it with transaction code "S" as an open-market sale of 26 shares of common stock at $287.50 per share.

Does Amy W. Schulman hold Elevance Health (ELV) shares directly or indirectly after this transaction?

Following the transaction, Amy W. Schulman’s 218 Elevance Health shares are reported as held directly. The Form 4 indicates direct ownership with the code "D", and there are no derivative positions listed in the filing’s derivative summary.